Mexico City. The Board of Directors of the Mexican Association of Pharmaceutical Research Industries AC (AMIIF), formalized the appointment and protest of Irma Egoavil as president of the Association for the rest of the period March 2020- March 2021.
Irma Egoavil, General Director of Ferring México and who previously served as Vice President of AMIIF, takes over from Ana Longoria, who will assume a new role at Novartis.
With Irma Egoavil in the presidency, the AMIIF will continue:
· Building alliances between the public sector, academia, civil society and the private sector to promote timely access to innovative therapies that have a significant and positive impact on people’s lives.
· Generating proposals that point towards the sustainability of the national health system in terms of coverage, financing and quality.
· Promoting the clinical research agenda and a knowledge economy that encourages, fosters and protects innovation.
· Promoting solid regulatory systems and high quality standards.
· Reinforcing the social agenda of this industry to achieve a greater impact on the health system and on society in general.
In Mexico, the innovative pharmaceutical industry has served as a strategic sector for economic and social development for 70 years. AMIIF member companies invest around $ 300 million annually in clinical research and generate 55,000 direct jobs and more than 240,000 indirect jobs.
Irma is a doctor graduated from La Salle University, has experience in research in child nutrition, having collaborated in the Nutrition Research unit of the Pediatric Hospital of the Centro Médico Nacional Siglo XXI. She studied pharmaceutical marketing at the INSEAD Business School in France and a master’s degree in Bioethics and Law at the University of Barcelona.
He has more than 23 years of experience in the pharmaceutical market in Mexico and Spain, as well as more than 12 years in highly specialized areas, achieving results through team development and promoting the integration of multidisciplinary teams. She has worked in companies such as Janssen, Roche and Celgene where she was the first employee in Mexico and had the opportunity to open the affiliate and start operations in Mexico. Since October 2016, she has been the General Director of Ferring México, where she is in charge of the commercial and manufacturing operations. She has been a member of the Board of Directors of AMIIF for three years and leads the Communication Commission of the Association.